WordNet

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 胃癌の危険因子 risk factors for gastric cancer
2. 胃癌の臨床的特徴、診断、および病期分類 clinical features diagnosis and staging of gastric cancer
3. 早期胃癌：疫学、臨床症状、診断、および病期分類 early gastric cancer epidemiology clinical manifestations diagnosis and staging
4. 胃癌スクリーニングおよび予防 screening and prevention of gastric cancer
5. 遺伝性のびまん性胃癌 hereditary diffuse gastric cancer

Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.

Boyce M1, van den Berg F2, Mitchell T2, Darwin K2, Warrington S2.
European journal of clinical pharmacology.Eur J Clin Pharmacol.2016 Oct 29. [Epub ahead of print]
PURPOSE: Hypergastrinaemia induced by proton pump inhibitor (PPI) therapy may cause ECL-cell and parietal-cell hyperplasia and rebound hyperacidity and dyspepsia after PPI withdrawal. The aim of the study was to assess the effect of different dosage-regimens of netazepide, a gastrin/CCK2 receptor an
PMID 27796466

A Prospective, Placebo-Controlled Pilot Evaluation of the Effect of Omeprazole on Serum Calcium, Magnesium, Cobalamin, Gastrin Concentrations, and Bone in Cats.

Gould E1, Clements C1, Reed A1, Giori L1, Steiner JM2, Lidbury JA2, Suchodolski JS2, Brand M1, Moyers T1, Emery L1, Tolbert MK1.
Journal of veterinary internal medicine.J Vet Intern Med.2016 May;30(3):779-86. doi: 10.1111/jvim.13932. Epub 2016 Apr 8.
BACKGROUND: Chronic proton pump inhibitor administration has been associated with electrolyte and cobalamin deficiency, disrupted bone homeostasis, hypergastrinemia, and rebound acid hypersecretion in humans. It is unknown if this occurs in cats.OBJECTIVES: Prolonged oral omeprazole results in alter
PMID 27062346

Perspectives in Drug Development and Clinical Pharmacology: The Discovery of Histamine H1 and H2 Antagonists.

Jones AW1.
Clinical pharmacology in drug development.Clin Pharmacol Drug Dev.2016 Jan;5(1):5-12. doi: 10.1002/cpdd.236.
Knowledge about the history and development of therapeutic agents holds a central position in the education and training of pharmacists and pharmacologists. Students enjoy learning about the discovery of drugs, including details about the pioneer workers involved (apothecaries, organic chemists, pha
PMID 27119574